These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9736177)

  • 21. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A clinical and pathological analysis of 22 cases of primary sclerosing cholangitis].
    Liu HH; Fu JL; Luo SQ; Sun YL; Dong JH; Guo TS; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):125-8. PubMed ID: 23663885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.
    Sterling RK; Salvatori JJ; Luketic VA; Sanyal AJ; Fulcher AS; Stravitz RT; Contos MJ; Mills AS; Shiffman ML
    Aliment Pharmacol Ther; 2004 Nov; 20(9):943-9. PubMed ID: 15521841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis.
    Lindström L; Hultcrantz R; Boberg KM; Friis-Liby I; Bergquist A
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):841-6. PubMed ID: 23353641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis.
    Rost D; Rudolph G; Kloeters-Plachky P; Stiehl A
    Dig Dis Sci; 2006 Mar; 51(3):618-22. PubMed ID: 16614977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic.
    Davies YK; Cox KM; Abdullah BA; Safta A; Terry AB; Cox KL
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):61-7. PubMed ID: 18607270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses.
    van Hoogstraten HJ; Wolfhagen FH; van de Meeberg PC; Kuiper H; Nix GA; Becx MC; Hoek AC; van Houte DP; Rijk MC; Salemans JM; Scherpenisse J; Schrijver M; Smit AM; Spoelstra P; Stadhouders PH; Tan TG; Hop WC; ten Kate FJ; vanBerge-Henegouwen GP; Schalm SW; van Buuren HR
    J Hepatol; 1998 Sep; 29(3):417-23. PubMed ID: 9764988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis.
    Deneau MR; Mack C; Mogul D; Perito ER; Valentino PL; Amir AZ; DiGuglielmo M; Draijer LG; El-Matary W; Furuya KN; Gupta N; Hochberg JT; Horslen S; Jensen MK; Jonas MM; Kerkar N; Koot BGP; Laborda TJ; Lee CK; Loomes KM; Martinez M; Miethke A; Miloh T; Mohammad S; Ovchinsky N; Rao G; Ricciuto A; Sathya P; Schwarz KB; Shah U; Singh R; Vitola B; Zizzo A; Guthery SL
    Hepatology; 2021 Mar; 73(3):1061-1073. PubMed ID: 32946600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary sclerosing cholangitis.
    Stiehl A; Benz C; Sauer P
    Can J Gastroenterol; 2000 Apr; 14(4):311-5. PubMed ID: 10799084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary sclerosing cholangitis].
    Stiehl A
    Internist (Berl); 2004 Jan; 45(1):27-32. PubMed ID: 14735241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sclerosing cholangitis with granulocytic epithelial lesion: a benign form of sclerosing cholangiopathy.
    Zen Y; Grammatikopoulos T; Heneghan MA; Vergani D; Mieli-Vergani G; Portmann BC
    Am J Surg Pathol; 2012 Oct; 36(10):1555-61. PubMed ID: 22982898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune hepatitis overlapping with primary sclerosing cholangitis.
    Takiguchi J; Ohira H; Rai T; Shishido S; Tojo J; Sato Y; Kasukawa R; Watanabe H; Funabashi Y; Kumakawa H
    Intern Med; 2002 Sep; 41(9):696-700. PubMed ID: 12322794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective single-center review of primary sclerosing cholangitis in children.
    Miloh T; Arnon R; Shneider B; Suchy F; Kerkar N
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):239-45. PubMed ID: 19121649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment.
    Rudolph G; Gotthardt DN; Kloeters-Plachky P; Kulaksiz H; Schirmacher P; Stiehl A
    Dig Dis Sci; 2011 Dec; 56(12):3624-30. PubMed ID: 21656181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
    Triantos CK; Koukias NM; Nikolopoulou VN; Burroughs AK
    Aliment Pharmacol Ther; 2011 Oct; 34(8):901-10. PubMed ID: 21883323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis.
    Stiehl A
    Scand J Gastroenterol Suppl; 1994; 204():59-61. PubMed ID: 7824879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
    Lindberg BU; Broomé U; Persson B
    Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis.
    Rost D; Rudolph G; Kloeters-Plachky P; Stiehl A
    Hepatology; 2004 Sep; 40(3):693-8. PubMed ID: 15349909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A child with primary sclerosing cholangitis].
    Rademaker AA; Benninga MA; Beuers UH; Plötz FB
    Ned Tijdschr Geneeskd; 2015; 159():A8312. PubMed ID: 25827146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective.
    Cullen SN; Rust C; Fleming K; Edwards C; Beuers U; Chapman RW
    J Hepatol; 2008 May; 48(5):792-800. PubMed ID: 18314215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.